Cardinal Health Inc

CAH has decisively broken below near-term support at ~$234.25 on strong volume, activating a bearish Support Failure pattern and reflecting a Stage 3 distribution environment. This breakdown signals failure of buyer absorption and opens the path toward $230 and the 200-day SMA near $216. Short-term conditions are unfavorable for bulls, with price tracking below the 9/20 EMAs and rising selling pressure. The preferred approach is to sell into any rallies toward the $235–$238 zone or on continued downside, with invalidation only on a sustained recovery above the broken support.

• ↑Q4 revenue reached $63.7B (+6% YoY) with GAAP EPS $1.70 (+70%).
• ↑Adjusted free cash flow of $5.0B supports $0.5158/share dividend and buybacks.
• ↓Negative earnings yield and low book-to-price suggest potential overvaluation.